Literature DB >> 17645504

Plasticity of ovarian cancer cell SKOV3ip and vasculogenic mimicry in vivo.

M Su1, Y-J Feng, L-Q Yao, M-J Cheng, C-J Xu, Y Huang, Y-Q Zhao, H Jiang.   

Abstract

The aim of this study is to investigate the plasticity of human epithelial ovarian cancer cell SKOV3ip and formation of vasculogenic mimicry (VM) in vivo. SKOV3ip was transfected with lentiviral vector carrying green fluorescence protein (GFP). Female nude mice were implanted intraperitoneally with GFP-labled SKOV3ip. When the transplanted tumor reached a volume of approximately 1 cm(3), paraffin-embedded, formaldehyde-fixed tissue was prepared and stained with hematoxylin and eosin (H & E). Tumor tissues were also studied by electron microscopy and fluorescence microscopy. The results of H & E staining, electron microscopy, and fluorescence microscopy indicated SKOV3ip formed patterned networks with erythrocytes in them, in the absence of vascular epithelial cells, which was a sign that SKOV3ip engaged in VM in vivo. Expression of vascular epithelium marker CD31 was investigated by immunohistochemical staining, immunofluorescence assay, semiquantitative reverse transcriptase-polymerase chain reaction (RT-PCR), and flow cytometric analysis (FACS). Factor VIII and vascular endothelial growth factor (VEGF) were also analyzed by FACS. Weak and focal CD31 immunohistochemical staining was found along the channels of tumor cells. Immunofluorescence assay and RT-PCR demonstrated that CD31 was expressed in primary-cultured SKOV3ip. CD31 and Factor VIII, but not VEGF were detected in primary-cultured SKOV3ip by FACS. The present study has shown that human ovarian cancer cell line SKOV3ip may be able to express some specific markers of vascular epithelial cells and has plasticity to form VM in vivo. In the following study, we indicated that hypoxia-inducible factor (HIF)-1alpha inhibitor, rapamycin, could possibly prevent VM and phenotype transformation of SKOV3ip, reflected by down-regulating expression of CD31 and Factor VIII. HIF-1alpha protein expression correlated with CD31 and Factor VIII protein expression in SKOV3ip. These results indicated that VM might be associated with HIF-1alpha.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17645504     DOI: 10.1111/j.1525-1438.2007.01034.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  24 in total

1.  Immunohistochemistry in the evaluation of neovascularization in tumor xenografts.

Authors:  D Wang; C R Stockard; L Harkins; P Lott; C Salih; K Yuan; D Buchsbaum; A Hashim; M Zayzafoon; R W Hardy; O Hameed; W Grizzle; G P Siegal
Journal:  Biotech Histochem       Date:  2008-06       Impact factor: 1.718

2.  Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications.

Authors:  Dawn A Kirschmann; Elisabeth A Seftor; Katharine M Hardy; Richard E B Seftor; Mary J C Hendrix
Journal:  Clin Cancer Res       Date:  2012-04-02       Impact factor: 12.531

3.  Pivotal role of pervasive neoplastic and stromal cells reprogramming in circulating tumor cells dissemination and metastatic colonization.

Authors:  Didier Meseure; Kinan Drak Alsibai; Andre Nicolas
Journal:  Cancer Microenviron       Date:  2014-12-19

4.  Molecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapy.

Authors:  Yue-Zu Fan; Wei Sun
Journal:  World J Gastrointest Surg       Date:  2010-04-27

Review 5.  Contribution of cancer stem cells to tumor vasculogenic mimicry.

Authors:  Xiao-hong Yao; Yi-fang Ping; Xiu-wu Bian
Journal:  Protein Cell       Date:  2011-04-29       Impact factor: 14.870

6.  Establishment and Characterization of Orthotopic Mouse Models for Human Uveal Melanoma Hepatic Colonization.

Authors:  Shinji Ozaki; Raja Vuyyuru; Ken Kageyama; Mizue Terai; Masahiro Ohara; Hanyin Cheng; Tim Manser; Michael J Mastrangelo; Andrew E Aplin; Takami Sato
Journal:  Am J Pathol       Date:  2015-11-25       Impact factor: 4.307

7.  The proliferation, apoptosis, invasion of endothelial-like epithelial ovarian cancer cells induced by hypoxia.

Authors:  Pengfei Zhu; Yanxia Ning; Liangqing Yao; Mo Chen; Congjian Xu
Journal:  J Exp Clin Cancer Res       Date:  2010-09-10

Review 8.  Tumor cell vasculogenic mimicry: from controversy to therapeutic promise.

Authors:  Richard E B Seftor; Angela R Hess; Elisabeth A Seftor; Dawn A Kirschmann; Katharine M Hardy; Naira V Margaryan; Mary J C Hendrix
Journal:  Am J Pathol       Date:  2012-08-31       Impact factor: 4.307

Review 9.  Vascular mimicry: changing the therapeutic paradigms in cancer.

Authors:  Nazila Fathi Maroufi; Sina Taefehshokr; Mohammad-Reza Rashidi; Nima Taefehshokr; Mahdieh Khoshakhlagh; Alireza Isazadeh; Narmin Mokarizadeh; Behzad Baradaran; Mohammad Nouri
Journal:  Mol Biol Rep       Date:  2020-05-18       Impact factor: 2.316

10.  IRX1 influences peritoneal spreading and metastasis via inhibiting BDKRB2-dependent neovascularization on gastric cancer.

Authors:  J Jiang; W Liu; X Guo; R Zhang; Q Zhi; J Ji; J Zhang; X Chen; J Li; J Zhang; Q Gu; B Liu; Z Zhu; Y Yu
Journal:  Oncogene       Date:  2011-05-23       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.